Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence

COSMOS study shows Guardant Reveal™ blood test highly predictive for disease recurrence in patients with early-stage colon cancer without need for tissue specimen

...

Related Keywords

San Francisco ,California ,United States , ,Nasdaq ,Facebook ,Guardant Health ,Exchange Commission ,Guardant Health Inc ,Linkedin ,Guardant Reveal ,Cancers Symposium ,Guardant Infinity ,Craig Eagle ,Minimal Residual Disease Detection ,Addressing Challenges ,Occult Metastatic Disease ,Oral Abstract Session ,Financial Condition ,Annual Report ,Markets ,